Justin Schreiber | executive |
Marc Benathen | executive |
David Larsen | analyst |
Sarah James | analyst |
William Wood | analyst |
Alex Fuhrman | analyst |
Good afternoon. Thank you for joining us today to discuss LifeMD's results for the first quarter ended March 31, 2024.
Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, Chief Financial Officer.
Following management's prepared remarks, we will open the call for a question-and-answer session.
Before we begin, I would like to remind everyone that during this call, the company will make a number of forward-looking statements which are subject to numerous risks and uncertainties that may cause actual results to differ materially from those projected.